CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $477,000 | -60.7% | 587,011 | +37.3% | 0.02% | -65.5% |
| Q4 2017 | $1,214,000 | -14.3% | 427,578 | -13.6% | 0.06% | -28.6% |
| Q3 2017 | $1,416,000 | +19.4% | 495,018 | +3.1% | 0.08% | -21.4% |
| Q2 2017 | $1,186,000 | +39.2% | 480,018 | +103.4% | 0.10% | +15.3% |
| Q1 2017 | $852,000 | +22.4% | 236,055 | +20.0% | 0.08% | +1.2% |
| Q4 2016 | $696,000 | +12.3% | 196,715 | +28.1% | 0.08% | +2.4% |
| Q3 2016 | $620,000 | -6.2% | 153,587 | +2.0% | 0.08% | -11.8% |
| Q2 2016 | $661,000 | +88.9% | 150,643 | +62.5% | 0.09% | +322.7% |
| Q1 2016 | $350,000 | -54.8% | 92,694 | +87.5% | 0.02% | -77.6% |
| Q4 2015 | $775,000 | – | 49,436 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |